Deals Shaping the Medical Industry (06/2009)
Executive Summary
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
You may also be interested in...
Did FDA's Pain Med Warning Scare Shionogi Away From Victory?
Has Victory been turned into defeat? The abrupt and mysterious evaporation of Shionogi's plans to buy Victory Pharma for $150 million is fueling speculation that Japanese pharma got cold feet about the deal, possibly because of FDA's shifting policy on pain products
Did FDA's Pain Med Warning Scare Shionogi Away From Victory?
Deal to buy Victory, maker of acetaminophen-combo products, disappears into thin air soon after liver injury scare.
Did FDA's Pain Med Warning Scare Shionogi Away From Victory?
Deal to buy Victory, maker of acetaminophen-combo products, disappears into thin air soon after liver injury scare.